Pfizer Inc. (PFE)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:05PM EST
After hours:
| Previous close | 43.97 |
| Open | 43.63 |
| Bid | 0.00 x 1300 |
| Ask | 0.00 x 4000 |
| Day's range | 43.50 - 44.46 |
| 52-week range | 41.45 - 56.32 |
| Volume | |
| Avg. volume | 21,858,740 |
| Market cap | 248.894B |
| Beta (5Y monthly) | 0.63 |
| PE ratio (TTM) | 8.11 |
| EPS (TTM) | 5.47 |
| Earnings date | 01 May 2023 - 05 May 2023 |
| Forward dividend & yield | 1.64 (3.73%) |
| Ex-dividend date | 26 Jan 2023 |
| 1y target est | 52.96 |
- Yahoo Finance
COVID is 'pretty much out of the models' for pharma companies: Wells Fargo analyst
Companies whose businesses were buoyed or boosted by Covid product demand are facing a cliff in 2023, and will have to pivot to more traditional strategies.
- Yahoo Finance Video
Pharma earnings: COVID ‘is highly uncertain for this year,’ analyst says
Wells Fargo Managing Director Mohit Bansal joins Yahoo Finance Live to discuss pharmaceutical earnings amid COVID uncertainty, the impact of diabetic weight loss drugs on the market, and the outlook for drugmakers.
- Zacks
Bristol-Myers (BMY) Q4 Earnings Top, Revlimid Generic Impact Sales
Bristol-Myers' (BMY) fourth-quarter 2022 earnings beat estimates, while sales declined year over year due to generic erosion for oncology drug Revlimid.
© 2023 Yahoo. All rights reserved.
